Novartis collaboration aims to eliminate rheumatic heart disease in Zambia, Africa Novartis today announced that it offers launched an attempt to eliminate rheumatic heart disease in Zambia in collaboration with the Lusaka University Teaching Medical center , the Ministry of Wellness in Zambia, the Pan-African Cardiology Society and Massachusetts General Medical center . RHD can be a complication of untreated streptococcal infections in which the valves of the heart are scarred and eventually degenerate, leading to heart failure. Eliminated by antibiotic treatment in most developed nations, in the developing world an estimated 15 million children have problems with this debilitating and frequently fatal disease.

Related StoriesMedflow announces option of advanced cloud-structured EHR systemStudy: 10 percent of healthcare providers prescribe antibiotics for individuals with frosty, bronchitis or additional ARIFalcon Physician wins Gold Stevie Award in IT Department of the Year category’This streamlined approach will help us get up and running much faster than would be possible if we’d to customize the EHR ourselves from the box,’ commented Meyers. ‘We’ll make use of guidelines from groups who’ve already implemented the product, while still having the ability to customize it later on to individual provider preferences.’ CPMG, which gives management solutions to a complete of 350 providers, is certainly in discussions with non-PAL procedures about the possibility of providing access to the Allscripts EHR.